基于知识的正黄病毒减毒活疫苗环境风险缓解策略:靶向病毒编码的蚊虫减毒表型决定簇
本综述讨论正黄病毒在蚊虫组织感染和播散中的病毒编码决定簇知识,这些知识可用于合理设计候选减毒活疫苗。黄热病17D和日本脑炎SA14-14-2疫苗株均不能在蚊虫中有效感染和播散,其蚊虫减毒表型也确保了IMOJEV、Dengvaxia和QDENGA等已上市减毒活疫苗的安全性。21世纪监管机构期望候选正黄病毒减毒活疫苗在实验室条件下展示在节肢动物媒介中复制和播散减少,以支持环境风险评估。
要点
- 黄热病17D和日本脑炎SA14-14-2减毒活疫苗株不能在蚊虫中有效感染和播散。
- 蚊虫减毒表型也确保了IMOJEV、Dengvaxia和QDENGA等已上市减毒活疫苗的安全性。
- 在蚊虫中达到安全减毒水平需要多基因突变以防止回复为野生型表型。
核心结论
- 正黄病毒在蚊虫组织感染和播散中的病毒编码决定簇知识可用于合理设计候选减毒活疫苗。
- 已发现的若干减毒突变位于正黄病毒间保守的基因组区域,可能支持建立广泛有效的减毒策略。
研究设计与样本
- 本综述讨论正黄病毒在蚊虫组织感染和播散中的病毒编码决定簇知识及其对合理设计候选减毒活疫苗的潜在用途。
主要发现
- 黄热病17D和日本脑炎SA14-14-2减毒活疫苗株均不能在蚊虫中有效感染和播散。
- 蚊虫减毒表型也确保了已上市减毒活疫苗IMOJEV、Dengvaxia和QDENGA的安全性。
- 在蚊虫中达到安全减毒水平需要多基因突变以防止回复为野生型表型。
- 已发现的若干减毒突变位于正黄病毒间保守的基因组区域。
临床怎么用
- 21世纪监管机构期望候选正黄病毒减毒活疫苗在实验室条件下展示在节肢动物媒介中复制和播散减少,以支持环境风险评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Many mosquito-borne orthoflaviviruses are important public health problems. Vaccination is critical for disease control because there is no licensed antiviral therapy for any orthoflavivirus. Live-attenuated vaccines (LAVs) that elicit protective immunity with one single immunization are the most effective tool for disease control, as shown by the success of implementing yellow fever (YF) 17D and Japanese encephalitis (JE) SA14-14-2 vaccines in routine immunization programs within endemic regions. Importantly, neither the YFV 17D strain nor the JEV SA14-14-2 LAV strain are mosquito-competent, meaning that neither vaccine strain can effectively infect and disseminate in mosquito tissues following engorgement of viremic blood. The mosquito-attenuated phenotype also ensures the safety of the licensed LAVs IMOJEV, Dengvaxia and QDENGA. In the 21st century, regulators expect the attenuated phenotype of candidate orthoflavivirus LAVs to also include a demonstration of reduced replication and dissemination in arthropod vectors under laboratory conditions in order to support environmental risk assessments of the impacts of these LAVs in nature. Achieving a safe level of attenuation of orthoflaviviruses in mosquitoes requires multigenic mutations to prevent reversion to the wild-type phenotype. This review discusses knowledge of orthoflaviviral encoded determinants for infection and dissemination in mosquito tissues which have potential utility for the rational design of candidate LAVs. Several attenuating mutations discovered to date are located within genomic regions that are conserved among orthoflaviviruses and can potentially support the establishment of a broadly effective attenuating strategy.
引用
- Mantlo EK, Huang YS. Knowledge-based mitigation of the environmental risk of Orthoflavivirus live-attenuated vaccines by targeting viral encoded determinants for the mosquito attenuated phenotype. Vaccine. 2025. PMID: 40252364. doi:10.1016/j.vaccine.2025.127114
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。